Lymphocyte cytosolic protein 2 is a novel prognostic marker in lung adenocarcinoma
Objective Lymphocyte cytosolic protein 2 (LCP2) is often ectopically expressed in various human tumors. However, the clinical significance and role of LCP2 in lung adenocarcinoma (LUAD) remain unclear. This study explored the prognostic significance of LCP2 in LUAD patients. Methods LCP2 expression...
Guardado en:
Autores principales: | Yishan Huo, Kainan Zhang, Songtao Han, Yangchun Feng, Yongxing Bao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aa5f3f99e38743f5b809e213ecae1d1a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma
por: Yang B, et al.
Publicado: (2021) -
Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma
por: Huan Zhang, et al.
Publicado: (2021) -
A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma
por: Yang Liu, et al.
Publicado: (2021) -
Diagnostic and prognostic potential of the oral and gut microbiome for lung adenocarcinoma
por: Mi Young Lim, et al.
Publicado: (2021) -
GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
por: Jiahui Han, et al.
Publicado: (2021)